"Artemisinins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of SESQUITERPENES and their analogs that contain a peroxide group (PEROXIDES) within an oxepin ring (OXEPINS).
| Descriptor ID |
D037621
|
| MeSH Number(s) |
D01.248.497.158.685.750.212 D01.339.431.374.212 D01.650.550.750.200 D02.389.338.055 D02.455.849.765.211
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Artemisinins".
Below are MeSH descriptors whose meaning is more specific than "Artemisinins".
This graph shows the total number of publications written about "Artemisinins" by people in this website by year, and whether "Artemisinins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Artemisinins" by people in Profiles.
-
Effects of dihydroartemisinin, a metabolite of artemisinin, on colon cancer chemoprevention and adaptive immune regulation. Mol Biol Rep. 2022 Apr; 49(4):2695-2709.
-
Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors. Nat Commun. 2019 04 23; 10(1):1899.
-
Immune suppressive properties of artemisinin family drugs. Pharmacol Ther. 2016 10; 166:123-7.
-
Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin. Oncogene. 2017 01 12; 36(2):254-262.
-
Preparation and Characterization of Solid Dispersions of Artemether by Freeze-Dried Method. Biomed Res Int. 2015; 2015:109563.
-
Artesunate abolishes germinal center B cells and inhibits autoimmune arthritis. PLoS One. 2014; 9(8):e104762.
-
Dihydroartemisinin inhibits tumor growth of human osteosarcoma cells by suppressing Wnt/ß-catenin signaling. Oncol Rep. 2013 Oct; 30(4):1723-30.